642 related articles for article (PubMed ID: 35534697)
1. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Lipid Nanoformulations for Effective mRNA Delivery.
Chen H; Ren X; Xu S; Zhang D; Han T
Int J Nanomedicine; 2022; 17():2893-2905. PubMed ID: 35814615
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology.
Ottonelli I; Adani E; Bighinati A; Cuoghi S; Tosi G; Vandelli MA; Ruozi B; Marigo V; Duskey JT
Int J Nanomedicine; 2024; 19():4235-4251. PubMed ID: 38766661
[TBL] [Abstract][Full Text] [Related]
4. Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids.
Ma X; Wu F; Peng C; Chen H; Zhang D; Han T
Biotechnol J; 2023 Nov; 18(11):e2300123. PubMed ID: 37545293
[TBL] [Abstract][Full Text] [Related]
5. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
Lou G; Anderluzzi G; Schmidt ST; Woods S; Gallorini S; Brazzoli M; Giusti F; Ferlenghi I; Johnson RN; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2020 Sep; 325():370-379. PubMed ID: 32619745
[TBL] [Abstract][Full Text] [Related]
6. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
7. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery.
He ZY; Zheng X; Wu XH; Song XR; He G; Wu WF; Yu S; Mao SJ; Wei YQ
Int J Pharm; 2010 Sep; 397(1-2):147-54. PubMed ID: 20667672
[TBL] [Abstract][Full Text] [Related]
8. Multicomponent Lipid Nanoparticles for RNA Transfection.
Gretskaya N; Akimov M; Andreev D; Zalygin A; Belitskaya E; Zinchenko G; Fomina-Ageeva E; Mikhalyov I; Vodovozova E; Bezuglov V
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111773
[TBL] [Abstract][Full Text] [Related]
9. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
[TBL] [Abstract][Full Text] [Related]
10. PEG-OligoRNA Hybridization of mRNA for Developing Sterically Stable Lipid Nanoparticles toward In Vivo Administration.
Kurimoto S; Yoshinaga N; Igarashi K; Matsumoto Y; Cabral H; Uchida S
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987102
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9.
Hosseini ES; Nikkhah M; Hosseinkhani S
Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265
[No Abstract] [Full Text] [Related]
12. Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells.
Lee CH; Ni YH; Chen CC; Chou C; Chang FH
Biochim Biophys Acta; 2003 Apr; 1611(1-2):55-62. PubMed ID: 12659945
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
[TBL] [Abstract][Full Text] [Related]
14. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
15. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
16. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
17. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition-A formulation screening study.
Holsæter AM; Wizgird K; Karlsen I; Hemmingsen JF; Brandl M; Škalko-Basnet N
Eur J Pharm Sci; 2022 Oct; 177():106267. PubMed ID: 35872073
[TBL] [Abstract][Full Text] [Related]
18. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
19. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
20. DOTAP: Structure, hydration, and the counterion effect.
Mihailescu M; Worcester DL; Carroll CL; Chamberlin AR; White SH
Biophys J; 2023 Mar; 122(6):1086-1093. PubMed ID: 36703558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
